Standard
Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. / Sorgenfrei, Iben F; Norrild, Kathrine; Larsen, Per Bo; Stensballe, Jakob; Ostergaard, Doris; Prins, Martine E; Viby-Mogensen, Jørgen.
In:
Anesthesiology, Vol. 104, No. 4, 01.04.2006, p. 667-74.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Sorgenfrei, IF, Norrild, K, Larsen, PB, Stensballe, J, Ostergaard, D, Prins, ME & Viby-Mogensen, J 2006, 'Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study', Anesthesiology, vol. 104, no. 4, pp. 667-74.
APA
Sorgenfrei, I. F., Norrild, K., Larsen, P. B., Stensballe, J., Ostergaard, D., Prins, M. E., & Viby-Mogensen, J. (2006). Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology, 104(4), 667-74.
Vancouver
Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology. 2006 Apr 1;104(4):667-74.
Author
Sorgenfrei, Iben F ; Norrild, Kathrine ; Larsen, Per Bo ; Stensballe, Jakob ; Ostergaard, Doris ; Prins, Martine E ; Viby-Mogensen, Jørgen. / Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. In: Anesthesiology. 2006 ; Vol. 104, No. 4. pp. 667-74.
Bibtex
@article{050c1077159a45e4af46599e37241d2c,
title = "Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study",
abstract = "Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced block.",
author = "Sorgenfrei, {Iben F} and Kathrine Norrild and Larsen, {Per Bo} and Jakob Stensballe and Doris Ostergaard and Prins, {Martine E} and J{\o}rgen Viby-Mogensen",
year = "2006",
month = apr,
day = "1",
language = "English",
volume = "104",
pages = "667--74",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams & Wilkins",
number = "4",
}
RIS
TY - JOUR
T1 - Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study
AU - Sorgenfrei, Iben F
AU - Norrild, Kathrine
AU - Larsen, Per Bo
AU - Stensballe, Jakob
AU - Ostergaard, Doris
AU - Prins, Martine E
AU - Viby-Mogensen, Jørgen
PY - 2006/4/1
Y1 - 2006/4/1
N2 - Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced block.
AB - Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced block.
M3 - Journal article
VL - 104
SP - 667
EP - 674
JO - Anesthesiology
JF - Anesthesiology
SN - 0003-3022
IS - 4
ER -
